NEW YORK (GenomeWeb News) – GATC Biotech today announced an expansion of its operations with the build-out of its existing facility, the creation of a new facility, and the hiring of new personnel.
As part of the planned expansion, the sequencing and bioinformatics service provider is expanding its headquarters in Konstanz, Germany and creating a new site in Cologne, Germany. The company said it will add 30 new jobs at the two sites in the coming year, which would bring the total number of employees to 170.
The Konstanz site will become the new European Genome and Diagnostics Center and be outfitted with next-generation sequencers such as Illumina's HiSeq 2000 and Pacific Biosciences' PacBio RS platforms, GATC said. The company will focus work at the site on sequencing projects, "offering its customers true multiplatform sequencing strategies."
Additionally, laboratories at GATC subsidiary LifeCodexx in Konstanz will be expanded to facilitate work centered on Trisomy 21. The firms announced during the summer they had begun a clinical validation study for a next-gen sequencing-based Trisomy 21 test being developed by LifeCodexx.
LifeCodexx also signed a deal with Sequenom in August to provide Trisomy 21 testing services based on Sequenom's technology.
The laboratory at Cologne will focus on single sample sequencing "due to its central location in Europe. "With the improved logistics and closeness to customers, the company will be able to offer [the] shortest delivery times and highly competitive prices," GATC said.